1. Intermittent HIV Treatment Increases Risk for HIV-Related Infections and Death Even After Resuming Continuous Treatment A recent trial showed that continuous treatment of HIV infection is better than stopping treatment when the patient’s immune status is good and restarting it when immune status deteriorates (interrupted treatment). At the end of this trial, patients assigned to intermittent treatment were begun on continuous treatment and observed for 18 months.
Popularity: unranked [?]
Related posts:
Comments
No Responses to “Clinical News From Annals Of Internal Medicine, Sept. 2, 2008”